✦ LIBER ✦

Evaluation of pharmacokinetics, efficacy and safety of Immunate® solvent detergent in previously treated patients with severe haemophilia A

✍ Scribed by L. NEMES; T. LISSITCHKOV; A. KLUKOWSKA; G. DOBACZEWSKI; V. KOMRSKA; R. ZIMMERMANN; G. AUERSWALD; W. ENGL; B. PAVLOVA; B. ABBÜHL; H. J. EHRLICH

Book ID: 108772730
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 429 KB
Volume: 13
Category: Article
ISSN: 1351-8216
DOI: 10.1111/j.1365-2516.2006.01412.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reformulated BeneFix®: efficacy and safe

Reformulated BeneFix®: efficacy and safety in previously treated patients with moderately severe to severe haemophilia B

✍ T. LAMBERT; M. RECHT; L. A. VALENTINO; J. S. POWELL; C. UDATA; S. T. SULLIVAN; D 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 597 KB

Clinical efficacy, safety and pharmacoki

Clinical efficacy, safety and pharmacokinetic properties of the factor VIII concentrate Haemoctin® SDH in previously treated patients with severe haemophilia A

✍ D. M. Wolf; R. Rokicka-Milewska; S. Lopaciuk; A. B. Skotnicki; A. Klukowska; P. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Clinical efficacy, safety and pharmacoki

Clinical efficacy, safety and pharmacokinetic properties of the plasma-derived factor IX concentrate Haemonine® in previously treated patients with severe haemophilia B

✍ M. SERBAN; A. B. SKOTNICKI; M. COLOVIC; C. JINCA; A. KLUKOWSKA; P. LAGUNA; D. M. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Clinical evaluation of an advanced categ

Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin-free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia A

✍ M. D. Tarantino; P. W. Collins; C. R. M. Hay; A.D. Shapiro; R. A. Gruppo; E. Ber 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 318 KB

Safety and efficacy of a sucrose-formula

Safety and efficacy of a sucrose-formulated recombinant factor VIII product for the treatment of previously treated patients with haemophilia A in China

✍ J. SHI; Y. ZHAO; J. WU; J. SUN; L. WANG; R. YANG 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 465 KB

Occurrence of inhibitors in previously u

Occurrence of inhibitors in previously untreated or minimally treated patients with haemophilia A after exposure to a plasma-derived solvent-detergent factor VIII concentrate

✍ A. GRINGERI; M. MONZINI; G. TAGARIELLO; F. A. SCARAGGI; P. M. MANNUCCI; THE EMOC 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB